Effectiveness of Anticoagulant Therapy on Coagulation Parameters in Patients with Ischemic Stroke: A Retrospective Study at Dr. M. Djamil General Hospital, Padang
Article Sidebar
Main Article Content
Page: 1767-1775
Abstract
Introduction: Ischemic stroke is a major cause of global morbidity and mortality, with anticoagulant therapy being the primary choice for secondary prevention in specific cases. However, scientific evidence regarding the effectiveness of anticoagulant therapy in the Indonesian population remains limited. Objective: To evaluate the effectiveness of anticoagulant therapy based on changes in coagulation parameters (PT, APTT, INR) and their association with clinical outcomes in ischemic stroke patients at Dr. M. Djamil General Hospital, Padang. Methods: This retrospective analytical observational study included 68 ischemic stroke patients who received anticoagulant therapy (January–December 2024). Effectiveness was assessed by changes in PT, APTT, and INR before and after treatment using Wilcoxon and Kruskal-Wallis tests. Results: Anticoagulant therapy significantly increased PT, APTT, and INR values in most treatment groups (p<0.05), with no significant differences among anticoagulant types (p>0.05). Patients with mortality outcomes showed higher increases in coagulation parameters, but a significant association was only found for changes in APTT (p=0.033). Conclusion: Anticoagulant therapy effectively affects coagulation parameters in ischemic stroke patients, and increased APTT after therapy is associated with mortality. Further prospective studies are needed to confirm these findings.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
. Gil-Garcia CA, Álvarez EF, Cebrian-Garcia R, Mendoza-Lopez AC, Gonzalez-Hermosillo LM, Garcia-Blanco MC, et al. Essential topics about the imaging diagnosis and treatment of hemorrhagic stroke: A comprehensive review of the 2022 AHA guidelines. Curr Probl Cardiol 2022;47(11):101328. https://doi.org/10.1016/j.cpcardiol.2022.101328.
. Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, et al. World Stroke Organization: Global stroke fact sheet 2025. Int J Stroke 2025;20(2):132–144. https://doi.org/10.1177/17474930241308142.
. Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia (SKI) 2023 dalam angka. Jakarta: Badan Kebijakan Pembangunan Kesehatan, Kementerian Kesehatan Republik Indonesia; 2023.
. Rilianto B, Kurniawan RG, Rajab NM, Prasetyo BT. Endovascular thrombectomy for acute ischemic stroke in Indonesia: Challenging and strategic planning. Neuropsychiatr Dis Treat 2024;20:621–630. https://doi.org/10.2147/NDT.S453629.
. Alhubaishi A, Almutairi MA, Alasqah MA, Alharthi SH, Alqahtani AM, Alnajjar LI. Evaluation of physicians' compliance with secondary prevention among ischemic stroke patients: A retrospective study. Cardiol Res 2023;14(4):302–308. https://doi.org/10.14740/cr1500.
. Choi HW, Luo T, Navia JA, Kassab GS. Role of aortic geometry on stroke propensity based on simulations of patient-specific models. Sci Rep 2017;7(1):7065. https://doi.org/10.1038/s41598-017-06681-3.
. Ribbat-Idel J, Stellmacher F, Jann F, Kalms N, König IR, Ohlrich M, et al. Development and reliability of the histological THROMBEX-classification rule for thrombotic emboli of acute ischemic stroke patients. Neurol Res Pract 2021;3(1):50. https://doi.org/10.1186/s42466-021-00149-6.
. Sablot D, Gaillard N, Belahsen F, Lamelo SR, Dumitrana A, Plantard C, et al. Direct oral anticoagulation versus no therapy or antiplatelet therapy for stroke prevention in patients with atrial fibrillation and a history of intracranial hemorrhage: A systematic review and meta-analysis. Front Med (Lausanne) 2025;12:1570809. https://doi.org/10.3389/fmed.2025.1570809.
. Roveny. Antikoagulan untuk stroke iskemik kardioemboli. Cermin Dunia Kedokteran 2015;42(5):344–347.
. DiPiro JT, Yee GC, Posey LM, Haines ST, Nolin TD, Ellingrod V. Pharmacotherapy: A pathophysiologic approach. 11th ed. New York: McGraw-Hill Education; 2020.
. Siguret V, Pautas E, Gouin-Thibault I. Warfarin therapy: Influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin. In: Vermeer C, editor. Vitamin K. London: Academic Press; 2008. p. 247–264.
. Nisila, Fatmawati ZI, Sucipto A. Hubungan jumlah penyakit penyerta dan tekanan darah dengan jenis stroke pada pasien stroke di Poli Saraf Rumah Sakit Sultan Imanuddin. Sci J Health 2025;2(1):138–153.
. Rahmadia PG. Asuhan keperawatan pada pasien dengan stroke iskemik di Bangsal Syaraf RSUP Dr. M. Djamil Padang. Padang: Poltekkes Kemenkes Padang; 2024.
. Dai X, Hummel SL, Salazar JB, Taffet GE, Zieman S, Schwartz JB. Cardiovascular physiology in older adults. J Geriatr Cardiol 2015;12(3):196–201. https://doi.org/10.11909/j.issn.1671-5411.2015.03.015.
. Diansari Y, Syahrir M, Yusuf SN. Profile of coagulation markers and influencing factors in central nervous system tumors. Maj Kedokt Sriwij 2019:164–171.
. Yan X, Wang B, Xia P, Lan C, Wang Q, Ge W, et al. Efficacy and safety of anticoagulant therapy versus antiplatelet therapy in acute ischemic stroke patients with atrial fibrillation. Clin Appl Thromb Hemost 2023;29:10760296231213070. https://doi.org/10.1177/10760296231213070.
. Dichgans M, Pulit SL, Rosand J. Stroke genetics: Discovery, biology, and clinical applications. Lancet Neurol 2019;18(6):587–599. https://doi.org/10.1016/S1474-4422(19)30043-2.
. Franklin BA, Rusia A, Haskin-Popp C, Tawney A. Chronic stress, exercise and cardiovascular disease: Placing the benefits and risks of physical activity into perspective. Int J Environ Res Public Health 2021;18(18):9922. https://doi.org/10.3390/ijerph18189922.
. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021;20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0.
. Ruksakulpiwat S, Zhou W, Phianhasin L, Benjasirisan C, Salehizadeh S, Wang L, et al. Associations between diagnosis of stroke, comorbidities, and activities of daily living among older adults in the United States. Chronic Dis Transl Med 2023;9(2):164–176. https://doi.org/10.1002/cdt3.60.
. Xian Y, Wu J, O'Brien EC, Fonarow GC, Olson DM, Schwamm LH, et al. Real-world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: Observational analysis from the PROSPER study. BMJ 2015;351:h3786. https://doi.org/10.1136/bmj.h3786.
. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): An open-label randomized comparison. Lancet 2007;369(9570):1347–1355. https://doi.org/10.1016/S0140-6736(07)60633-3.
. Mende J, Rahmawati F, Puspitasari I. Keamanan penggunaan antikoagulan pada pasien rawat inap stroke iskemik dengan fibrilasi atrium. J Manaj Farm 2022;12(3):176–188.
. Yang R, Zubair M, Moosavi L. Prothrombin Time. Treasure Island (FL): StatPearls Publishing; 2026. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544269/
. Dobesh PP, Terry KJ. Measuring or monitoring of novel anticoagulants: Which laboratory test to request? Curr Emerg Hosp Med Rep 2013;1:208–216. https://doi.org/10.1007/s40138-013-0029-z.
. Vene N, Mavri A. An overview of the anticoagulant drugs used in routine clinical practice. In: Anticoagulant Drugs. London: IntechOpen; 2018. https://doi.org/10.5772/intechopen.76206.
. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):160S–198S. https://doi.org/10.1378/chest.08-0670.
. Yusuf SN, Diansari Y, Syahrir M, Liana P, Bahar E. The comparison of effectiveness and safety between warfarin and rivaroxaban in hypercoagulated central nervous system tumors. Jambi Med J 2020;11:88–99.
. Iluț S, Vesa ȘC, Văcăraș V, Mureșanu DF. Predictors of short-term mortality in patients with ischemic stroke. Medicina (Kaunas) 2023;59(6):1142. https://doi.org/10.3390/medicina59061142.